Advertisement
Screener

ADAPTIVE BIOTECHNOLOGIES CORPORATION (ADPT) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

ADAPTIVE BIOTECHNOLOGIES CORPORATION Cash Flow Breakdown

Cash flow breakdown shows where ADAPTIVE BIOTECHNOLOGIES CORPORATION's cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $45.99M went out.
  • Fiscal year ended 2025-12-31: from investing, $37.95M came in.
  • Fiscal year ended 2025-12-31: from financing, $30.40M came in.
  • Fiscal year ended 2025-12-31: change in cash, $22.37M came in.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingNew shares soldOtherNot split outChange in cash
2025-12-31-$45.99M$37.95M$17.88M$12.52M*$22.37M
2024-12-31-$95.21M$77.79M$241.00K-$17.18M
2023-12-31-$156.32M$129.65M$2.25M-$24.43M
2022-12-31-$183.94M$2.90M$7.89M$124.38M*-$48.77M
2021-12-31-$192.73M$181.21M$26.72M$15.63M
2020-12-31-$149.68M-$117.04M$272.16M$21.43M*$26.86M
2019-12-31$205.40M-$481.70M$320.85M-$12.00K-$922.00K*$43.62M
2018-12-31-$32.26M$736.00K$1.27M-$20.00K-$30.27M
2017-12-31-$34.86M$36.43M$222.00K-$15.00K$49.83M*$51.61M

Each quarter (3 month)

Quarter endRunning the businessFrom investingNew shares soldOtherNot split outChange in cash
2026-06-30-$6.40M*-$43.48M*$5.38M*$136.81M*
2026-03-31-$9.54M$9.14M$5.03M$2.48M*$7.11M
2025-12-31$2.06M*-$8.25M*$9.13M*$12.52M*
2025-09-30-$7.13M*$17.28M*$1.68M*
2025-06-30-$12.43M*$3.35M*$1.61M*
2025-03-31-$28.48M$25.57M$5.45M$2.54M
2024-12-31-$12.49M*$22.12M*$127.00K*
2024-09-30-$27.07M*$5.29M*$40.00K*
2024-06-30-$17.30M*$5.88M*$30.00K*
2024-03-31-$38.35M$44.51M$44.00K$6.20M
2023-12-31-$26.93M*$3.21M*$87.00K*
2023-09-30-$46.68M*$26.14M*$17.00K*
2023-06-30-$23.56M*$37.32M*$1.47M*
2023-03-31-$59.15M$62.98M$672.00K$4.50M
2022-12-31-$30.02M*-$97.54M*$322.00K*
2022-09-30-$42.41M*$58.02M*$829.00K*$124.69M*
2022-06-30-$47.06M*$4.75M*$3.99M*
2022-03-31-$64.45M$37.69M$2.75M-$24.02M
2021-12-31-$53.83M*$67.21M*$3.28M*
2021-09-30-$43.44M*-$21.27M*$2.93M*
2021-06-30-$37.21M*$41.45M*$6.33M*
2021-03-31-$58.24M$93.82M$14.19M$50.19M
2020-12-31-$39.84M*-$340.05M*$0.00*$6.25M*
2020-09-30-$47.16M*-$97.25M*$4.20M*$271.84M*
2020-06-30-$31.08M*$177.49M*$6.34M*
2020-03-31-$31.61M$142.76M$4.96M$116.11M
2019-12-31-$26.79M*$46.68M*$0.00*-$2.00K*$1.75M*
2019-09-30-$30.14M*-$260.85M*$318.00K*-$1.00K*$319.23M*
2019-06-30-$15.97M*-$45.35M*$1.86M*-$3.00K*-$3.36M*
2019-03-31$278.30M-$222.18M$130.00K-$6.00K$56.25M
2018-12-31-$5.41M*$27.63M*$283.00K*-$5.00K*
2018-09-30-$11.69M*$5.13M*$62.00K*-$5.00K*

Similar stocks

Stock NameCountryMarket CapPE Ratio
IOVANCE BIOTHERAPEUTICS, INC. (IOVA)United States$4.897B-6.51
CRISPR Therapeutics AG (CRSP)$5.390B-11.68
Relay Therapeutics, Inc. (RLAY)United States$3.884B-14.30
Scholar Rock Holding Corp (SRRK)United States$5.920B-16.37
CG Oncology, Inc. (CGON)United States$6.095B-27.95
Tarsus Pharmaceuticals, Inc. (TARS)United States$3.329B-58.60
Denali Therapeutics Inc. (DNLI)United States$3.274B-8.04
Beam Therapeutics Inc. (BEAM)United States$2.549B-41.51
Immunovant, Inc. (IMVT)United States$7.028B-14.78
Greenland Mines Ltd (GRML)United States$2.362B